Cleared Traditional

K830472 - LIPOSOL

K830472 is the FDA 510(k) clearance for LIPOSOL by Quest Medical, Inc.. It is a Class 2 Chemistry device (product code JKA) cleared through the Traditional 510(k) pathway after a 113-day FDA review.

K830472 · Quest Medical, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1983
Decision
113d
Days
Class 2
Risk

K830472 is an FDA 510(k) clearance for the LIPOSOL. Classified as Tubes, Vials, Systems, Serum Separators, Blood Collection (product code JKA), Class II - Special Controls.

Submitted by Quest Medical, Inc. (Mchenry, US). The FDA issued a Cleared decision on June 8, 1983 after a review of 113 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1675 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Quest Medical, Inc. devices

Submission Details

510(k) Number K830472 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 15, 1983
Decision Date June 08, 1983
Days to Decision 113 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
25d slower than avg
Panel avg: 88d · This submission: 113d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JKA Tubes, Vials, Systems, Serum Separators, Blood Collection
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1675
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JKA Tubes, Vials, Systems, Serum Separators, Blood Collection

All 115
Devices cleared under the same product code (JKA) and FDA review panel - the closest regulatory comparables to K830472.
ISOSTAT MICROBIAL TUBE PROCESSING
K840496 · E.I. Dupont DE Nemours & Co., Inc. · Apr 1984
CAPIJECT SYS CAPILLARY BLOOD COLLECT
K833475 · Terumo Medical Corp. · Dec 1983
MONOJET SPS BLOOD COLLECTION TUBE
K831719 · Sherwood Medical Co. · Jul 1983
LITHIUM HEPARINIZED BLOOD COLLECT-TUBE
K831242 · American Dade · May 1983
MONOJECT SAMPLETTE CAPILLARY BLOOD COLL
K823836 · Sherwood Medical Co. · Jan 1983
MONOJECT SAMPLETTE CAPILLARY SERUM SEP
K823176 · Sherwood Medical Co. · Nov 1982